Hall of Fame player Dwyane Wade says doctors performed a December 2023 surgery on his kidney to remove a tumor later ...
Wade, who turned 43 earlier this month, said his father’s journey with prostate cancer inspired him to see a doctor after experiencing stomach issues, cramps and difficulty urinating. A tumor found in ...
Chronic kidney disease (CKD) is a growing global health concern, significantly contributing to morbidity and mortality rates worldwide. Characterized by a ...
ProKidney’s Rilparencel shows promise for CKD patients, with Phase 2 data expected in 2025. Learn why PROK stock is a “Buy” ...
Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...
The NBA Hall of Famer shared about his health scare and the toll it took on him and his family on his podcast.
KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.
You see somebody who’s in need and you know that you can do this and their life will change and be such a vast improvement ..
Using a handheld dynamometer to assess hip flexion and abduction strength during dialysis was reliable and safe, researchers found in a cross-sectional study.“Subjects in stages 3 and 4 of [chronic ...
(RTTNews) - Regulus Therapeutics Inc. (RGLS) Wednesday announced positive clinical as well as regulatory updates from its autosomal dominant polycystic kidney disease (ADPKD) program.
Vet Amir Anwary has revealed the five cat breeds he would not own himself, and it's all down to the fact that they are prone ...
SAN DIEGO - Regulus Therapeutics Inc . (NASDAQ:RGLS), a biopharmaceutical company currently trading at $1.17 per share, today announced significant clinical and regulatory advancements in its ...